Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies.
Ontology highlight
ABSTRACT: Polycomb repressive complexes (PRCs) are epigenetic regulators that mediate repressive histone modifications. PRCs play a pivotal role in the maintenance of hematopoietic stem cells through repression of target genes involved in cell proliferation and differentiation. Next-generation sequencing technologies have revealed that various hematologic malignancies harbor mutations in PRC2 genes, such as EZH2, EED, and SUZ12, and PRC1.1 genes, such as BCOR and BCORL1. Except for the activating EZH2 mutations detected in lymphoma, most of these mutations compromise PRC function and are frequently associated with resistance to chemotherapeutic agents and poor prognosis. Recent studies have shown that mutations in PRC genes are druggable targets. Several PRC2 inhibitors, including EZH2-specific inhi
SUBMITTER: Kaito S
PROVIDER: S-EPMC7793497 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA